Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More
GRANULES INDIA TEVA PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
GRANULES INDIA Mar-23 |
TEVA PHARMA Dec-13 |
GRANULES INDIA/ TEVA PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 381 | 3,479 | - | |
Low | Rs | 227 | 3,022 | - | |
Sales per share (Unadj.) | Rs | 186.4 | 1,996.4 | - | |
Earnings per share (Unadj.) | Rs | 21.3 | 124.7 | - | |
Cash flow per share (Unadj.) | Rs | 29.0 | 286.1 | - | |
Dividends per share (Unadj.) | Rs | 1.50 | 109.18 | - | |
Avg Dividend yield | % | 0.5 | 3.4 | 14.7% | |
Book value per share (Unadj.) | Rs | 116.4 | 2,217.6 | - | |
Shares outstanding (eoy) | m | 242.04 | 848.00 | - | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.6 | 1.6 | 100.2% | |
Avg P/E ratio | x | 14.2 | 26.1 | 54.7% | |
P/CF ratio (eoy) | x | 10.5 | 11.4 | 92.4% | |
Price / Book Value ratio | x | 2.6 | 1.5 | 178.3% | |
Dividend payout | % | 7.0 | 87.5 | 8.0% | |
Avg Mkt Cap | Rs m | 73,611 | 2,756,220 | 2.7% | |
No. of employees | `000 | NA | 44.9 | 0.0% | |
Total wages/salary | Rs m | 4,203 | 0 | - | |
Avg. sales/employee | Rs Th | 0 | 37,667.6 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 2,353.1 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 45,119 | 1,692,969 | 2.7% | |
Other income | Rs m | 143 | 0 | - | |
Total revenues | Rs m | 45,262 | 1,692,969 | 2.7% | |
Gross profit | Rs m | 9,133 | 463,620 | 2.0% | |
Depreciation | Rs m | 1,845 | 136,844 | 1.3% | |
Interest | Rs m | 559 | 33,253 | 1.7% | |
Profit before tax | Rs m | 6,872 | 293,523 | 2.3% | |
Minority Interest | Rs m | 0 | 1,333 | 0.0% | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | -192,682 | -0.0% | |
Tax | Rs m | 1,706 | -3,584 | -47.6% | |
Profit after tax | Rs m | 5,166 | 105,758 | 4.9% | |
Gross profit margin | % | 20.2 | 27.4 | 73.9% | |
Effective tax rate | % | 24.8 | -1.2 | -2,033.2% | |
Net profit margin | % | 11.4 | 6.2 | 183.3% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 25,741 | 1,143,425 | 2.3% | |
Current liabilities | Rs m | 18,135 | 997,163 | 1.8% | |
Net working cap to sales | % | 16.9 | 8.6 | 195.1% | |
Current ratio | x | 1.4 | 1.1 | 123.8% | |
Inventory Days | Days | 14 | 91 | 15.9% | |
Debtors Days | Days | 77 | 96 | 80.0% | |
Net fixed assets | Rs m | 23,290 | 552,961 | 4.2% | |
Share capital | Rs m | 242 | 4,167 | 5.8% | |
Net worth | Rs m | 28,169 | 1,880,567 | 1.5% | |
Long term debt | Rs m | 1,486 | 865,653 | 0.2% | |
Total assets | Rs m | 49,031 | 3,868,976 | 1.3% | |
Interest coverage | x | 13.3 | 9.8 | 135.2% | |
Debt to equity ratio | x | 0.1 | 0.5 | 11.5% | |
Sales to assets ratio | x | 0.9 | 0.4 | 210.3% | |
Return on assets | % | 11.7 | 3.6 | 325.0% | |
Return on equity | % | 18.3 | 5.6 | 326.1% | |
Return on capital | % | 25.1 | 4.9 | 508.1% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 7,387 | 269,772 | 2.7% | |
From Investments | Rs m | -1,914 | -95,591 | 2.0% | |
From Financial Activity | Rs m | -4,403 | -323,609 | 1.4% | |
Net Cashflow | Rs m | 1,068 | -149,429 | -0.7% |
Compare GRANULES INDIA With: MYLAN (US) ADCOCK INGRAM (S. Africa) ACTAVIS (US)
Compare GRANULES INDIA With: NUTRAPLUS PR IND. SWIFT CORAL LAB. LINK PHARMA ROOPA INDUSTRIES
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.